SK1292003A3 - Dementia remedies containing 2-aryl-8-oxodihydropurine derivatives as the active ingredient - Google Patents

Dementia remedies containing 2-aryl-8-oxodihydropurine derivatives as the active ingredient Download PDF

Info

Publication number
SK1292003A3
SK1292003A3 SK129-2003A SK1292003A SK1292003A3 SK 1292003 A3 SK1292003 A3 SK 1292003A3 SK 1292003 A SK1292003 A SK 1292003A SK 1292003 A3 SK1292003 A3 SK 1292003A3
Authority
SK
Slovakia
Prior art keywords
group
alkyl
dementia
amino
prevention
Prior art date
Application number
SK129-2003A
Other languages
English (en)
Slovak (sk)
Inventor
Kiyoshi Furukawa
Satoshi Kurumiya
Takashi Hashimoto
Original Assignee
Dainippon Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dainippon Pharmaceutical Co filed Critical Dainippon Pharmaceutical Co
Publication of SK1292003A3 publication Critical patent/SK1292003A3/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SK129-2003A 2000-07-31 2001-07-24 Dementia remedies containing 2-aryl-8-oxodihydropurine derivatives as the active ingredient SK1292003A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2000230209 2000-07-31
PCT/JP2001/006363 WO2002010167A1 (en) 2000-07-31 2001-07-24 Dementia remedies containing 2-aryl-8-oxodihydropurine derivatives as the active ingredient

Publications (1)

Publication Number Publication Date
SK1292003A3 true SK1292003A3 (en) 2003-08-05

Family

ID=18723200

Family Applications (1)

Application Number Title Priority Date Filing Date
SK129-2003A SK1292003A3 (en) 2000-07-31 2001-07-24 Dementia remedies containing 2-aryl-8-oxodihydropurine derivatives as the active ingredient

Country Status (19)

Country Link
US (1) US6962921B2 (cs)
EP (1) EP1306378A4 (cs)
KR (1) KR100829297B1 (cs)
CN (1) CN1247578C (cs)
AU (1) AU7278701A (cs)
BR (1) BR0112881A (cs)
CA (1) CA2416706C (cs)
CZ (1) CZ2003234A3 (cs)
HK (1) HK1054231A1 (cs)
HU (1) HUP0303714A3 (cs)
IL (1) IL154049A0 (cs)
MX (1) MXPA03000861A (cs)
NO (1) NO20030474L (cs)
NZ (1) NZ523812A (cs)
PL (1) PL363870A1 (cs)
RU (1) RU2277096C2 (cs)
SK (1) SK1292003A3 (cs)
WO (1) WO2002010167A1 (cs)
ZA (1) ZA200300549B (cs)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7760101B2 (en) * 2008-06-20 2010-07-20 Kimberly-Clark Worldwide, Inc. Method of reducing sensor corrosion in absorbent articles
ES2626246T3 (es) * 2009-09-09 2017-07-24 Sumitomo Dainippon Pharma Co., Ltd. Derivado de 8-oxodihidropurina
WO2012168697A1 (en) 2011-06-06 2012-12-13 Imperial Innovations Limited Methods to predict binding affinity of tspo imaging agents to tspo

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5453428A (en) * 1991-02-14 1995-09-26 The Mount Sinai School Of Medicine Of The City Of New York Method and composition for the treatment of apathy-amotivation syndrome
WO1993000074A1 (en) * 1991-06-26 1993-01-07 Sepracor, Inc. Method and compositions for treating emesis, nausea and other disorders using optically pure r(+) ondansetron
GB9208492D0 (en) * 1992-04-16 1992-06-03 Glaxo Spa Heterocyclic compounds
US5212195A (en) * 1992-05-13 1993-05-18 Syntex (U.S.A.) Inc. Substituted indole antagonists derivatives which are angiotensin II
JP4667543B2 (ja) 1996-07-03 2011-04-13 大日本住友製薬株式会社 新規プリン誘導体
ZA9810490B (en) 1997-12-03 1999-05-20 Dainippon Pharmaceutical Co 2-Aryl-8-oxodihydropurine derivative process for the preparation thereof pharmaceutical composition containing the same and intermediate therefor
DE69932449T2 (de) * 1998-12-18 2007-03-15 Scios Inc., Fremont Agonisten und antagonisten von benzodiazepinrezeptoren des peripheren typs
EP1140106B1 (en) * 1998-12-18 2005-08-03 Scios Inc. Treatment of diseases involving cyst formation
JP3814125B2 (ja) * 1999-06-02 2006-08-23 大日本住友製薬株式会社 2−アリール−8−オキソジヒドロプリン誘導体からなる医薬

Also Published As

Publication number Publication date
US6962921B2 (en) 2005-11-08
NO20030474L (no) 2003-03-27
CA2416706A1 (en) 2002-02-07
BR0112881A (pt) 2003-07-01
EP1306378A4 (en) 2005-02-09
CN1466587A (zh) 2004-01-07
MXPA03000861A (es) 2004-04-05
US20030166667A1 (en) 2003-09-04
CZ2003234A3 (cs) 2003-05-14
PL363870A1 (en) 2004-11-29
CA2416706C (en) 2009-04-07
RU2277096C2 (ru) 2006-05-27
ZA200300549B (en) 2003-08-19
NO20030474D0 (no) 2003-01-30
IL154049A0 (en) 2003-07-31
KR100829297B1 (ko) 2008-05-13
HUP0303714A2 (hu) 2004-03-01
AU7278701A (en) 2002-02-13
HK1054231A1 (en) 2003-11-21
WO2002010167A1 (en) 2002-02-07
CN1247578C (zh) 2006-03-29
HUP0303714A3 (en) 2007-03-28
EP1306378A1 (en) 2003-05-02
NZ523812A (en) 2004-07-30
KR20030019634A (ko) 2003-03-06

Similar Documents

Publication Publication Date Title
EP3570940B1 (en) Pridopidine for use in the treatment of fragile x syndrome
AU2021236532A1 (en) Methods and compositions for treating aging-associated impairments using CCR3-inhibitors
EP3085231A1 (en) Method and compositions for sleep disorders and other disorders
TW201822769A (zh) 用於治療非小細胞肺癌之egfr t790m 抑制劑及cdk抑制劑之組合
HUP0400966A2 (hu) NK3 receptor antagonisták alkalmazása megváltozott bélműködéssel és/vagy visceralis fájdalommal jellemzett állapotok kezelésére és/vagy megelőzésére
TW201536295A (zh) σ配體在與間質性膀胱炎/膀胱疼痛綜合徵(IC/BPS)相關的疼痛的預防和治療中的應用
CA2942821A1 (en) Application of 5-ht6 receptor antagonists for the alleviation of cognitive deficits of down syndrome
US20060211686A1 (en) Alpha7 Neuronal nicotinic receptor ligand and antipsychotic compositions
AU2011323899A1 (en) Methods of treatment and/or prevention of scleroderma, UV injury or sunburn, formation of scars or keloids by using haloaryl substituted Aminopurines
US5484788A (en) Buspirone as a systemic immunosuppressant
JP5591310B2 (ja) 4−{3−[cis−ヘキサヒドロシクロペンタ[c]ピロール−2(1H)−イル]プロポキシ}ベンズアミドとNMDA受容体アンタゴニストとの新規な組み合わせ、及びそれを含む医薬組成物
CZ20011999A3 (cs) Diazepinoindoly pro léčbu chronické obstrukční nemoci bronchopulmonální
CA2416706C (en) Dementia remedies containing 2-aryl-8-oxodihydropurine derivatives as the active ingredient
ITMI951417A1 (it) Composizioni farmaceutiche e procedimento per la loro preparazione
CA2159091C (en) Topical and systemic application of buspirone or derivatives thereof for treatment of pathological conditions associated with immune responses
SK12982002A3 (sk) Liečba chorôb vzťahujúcich sa na sérotonergný systém
BG63378B1 (bg) Използване на 1-ар(алк)ил-имидазолин-2-он за лечение на страхови и стресови състояния
WO2025248468A1 (en) Use of tyk2/jak1 inhibitors to treat amyloid-related imaging abnormalities (aria)
JP2003221337A (ja) 酢酸アミド誘導体を有効成分とする痴呆症治療剤
TW202502350A (zh) 化合物1在治療或預防肺纖維化或伴有纖維化的肺部疾病等疾病中的應用
JPWO2002010167A1 (ja) 2−アリール−8−オキソジヒドロプリン誘導体を有効成分とする痴呆症治療剤
PT689439E (pt) Utilizacao de compostos de triazina no fabrico de um medicamento para o tratamento de patologias da memoria e da aprendizagem
HK40029681A (en) Methods and compositions for treating pruritus, xerosis, and associated disease using ccr3-inhibitors
US20100227844A1 (en) Cannabinoid-1 receptor modulators useful for the treatment of alzheimer's disease
HK40019123A (en) Methods and compositions for treating aging-associated impairments using ccr3-inhibitors

Legal Events

Date Code Title Description
FB9A Suspension of patent application procedure